Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
All times are local (Market data is delayed by at least 15 minutes).

bone medical ltd-spons adr (BMEDY) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

bone medical ltd-spons adr (BMEDY) Related Businessweek News

No Related Businessweek News Found

bone medical ltd-spons adr (BMEDY) Details

Bone Medical Ltd, a specialty biopharmaceutical company, develops therapeutics to prevent and/or treat bone and joint diseases and conditions, primarily osteoporosis, osteoarthritis, and rheumatoid arthritis in Australia. The company’s product pipeline consists of Phase II clinical-stage programs and four preclinical programs. Its principal products include CaPTHymone, an oral parathyroid hormone for the treatment of osteoporosis; Capsitonin, an oral calcitonin for the treatment of osteoarthritis pain; and BN006, a synthetic oligopeptide with selective TNF-a and IL-6 inhibitory mechanism and the potential for oral administration. The company also develops BN005/BN008 cell regulators for the treatment of osteoporosis and arthritis. Bone Medical Ltd is based in West Perth, Australia.

bone medical ltd-spons adr (BMEDY) Top Compensated Officers

Senior Consultant
Total Annual Compensation: A$135.7K
Compensation as of Fiscal Year 2014.

bone medical ltd-spons adr (BMEDY) Key Developments

Bone Medical Ltd. Announces Executive and Management Changes

Bone Medical has announced plans to acquire Takor Group. Following completion of the takeover, Bone Medical will change its name to Takor Group and two of its existing directors, Robert Towner and Philip Wingate will resign. Mr. Farhand will become managing director, while Takor co-founder Ivan Gustavino and non-executive director Guy Perkins will also be appointed to the board.

Bone Medical Limited Announces Unaudited Consolidated Earnings Results for the First Half-Year Ended December 31, 2014

Bone Medical Limited announced unaudited consolidated earnings results for the first half-year ended December 31, 2014. For the half-year, the company reported total revenue from continuing operations AUD 31,169. Loss before income tax expense was AUD 734,676 against AUD 783,423 a year ago. Loss after income tax for the half year was AUD 734,676 or 0.28 cents per basic and diluted share against AUD 683,140 or 0.06 cents per basic and diluted share a year ago. Total comprehensive loss for the half year attributed to members of the company was AUD 734,676 against AUD 683,140 a year ago. Net cash used in operating activities was AUD 965,419 against AUD 307,789 a year ago. The net loss is attributable to expenditure in relation to research and development technologies, settlement of the outstanding debt with AustInvest and general administration costs associated with an ASX listed company.

Bone Medical Ltd. Announces Board Changes

Bone Medical Ltd. announced that Non-Executive Director Dr. Roger New has resigned, effective immediately. Dr. New has stepped down as part of the termination and settlement of the Proxima Group License and Services Agreements. Mr. Phillip Wingate has been appointed as a Non-Executive Director of the company. Mr. Wingate is currently also Company Secretary of ASX listed companies Orinoco Gold Limited and Potash Minerals Limited. Mr. Wingate currently serves as Company Secretary of the Company and will retain this position.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMEDY:US $0.00 USD 0.00

BMEDY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BMEDY.
View Industry Companies

Industry Analysis


Industry Average

Valuation BMEDY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BONE MEDICAL LTD-SPONS ADR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at